Global Monoclonal Antibodies Market Report By Type (Murine, Chimeric, Humanized, Human, Other), By Production Type (In Vivo, In Vitro), By Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases, Others), By End-use (Hospitals, Research Institutes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Monoclonal Antibodies Market Report
Brand: Value Market Research
SKU: Biotechnology
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212693

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Monoclonal Antibodies Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Monoclonal antibodies are identical immunoglobulins, generated from a single B-cell clone. It is an old immunological tool with applications in the fields of biochemistry, immunology, biotechnology, and applied biology. These are produced by the body's immune system in response to antigens such as bacteria, fungi, parasites, viruses, chemicals, and other substances. Scientists produce antibodies in the lab to mimic the action of the immune system to treat diseases with the help of immunotherapy. Monoclonal antibodies are generally administered by injection.

Market Dynamics

Production of monoclonal antibodies is an old practice in laboratory research. It is widely applied in the field of clinical medicine. Research from the laboratory globally is revealing additional applications in diverse branches of sciences. Growing search for new therapeutics is propelling the growth of the market. The continued interest in antibody product development is driven by the rapid advancement and understanding of disease at a molecular level. MAbs are extremely valuable for understanding basic immunological and molecular research due to their high specificity. MAbs are increasingly used for applications such as research and diagnosis, therapeutic tools in cancer and immunological disorders, and pharmacy, thus generating a great demand in the industry. Currently, MAbs account for one-third of all the new treatments for leukaemia, arthritis, breast cancer, and transplant, their role in disease prediction and detection offers promise. Scientist all over the world is looking for COVID-19 treatment. Ongoing research says that monoclonal antibodies could treat or even prevent COVID-19 and could promise as the next big thing for market.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of monoclonal antibodies.

Market Segmentation

The entire monoclonal antibodies market has been sub-categorized into type, production type, indication, and end user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Type

Murine
Chimeric
Humanized
Human
Other

By Production Type

In Vivo
In Vitro

By Indication

By End-Use

Hospitals
Research Institutes
Others

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for monoclonal antibodies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Monoclonal Antibodies Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the monoclonal antibodies market include Roche, Eli Lilly, Genentech, Pfizer, Biogen Idec. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Monoclonal Antibodies Market
       2.2. Global Monoclonal Antibodies Market Snapshot

3 . MONOCLONAL ANTIBODIES – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Monoclonal Antibodies Market
       3.3. Market Restraints of Monoclonal Antibodies Market
       3.4. Opportunities of Monoclonal Antibodies Market
      3.5. Trends of Monoclonal Antibodies Market
       3.6. Porter’s Five Force Analysis of Monoclonal Antibodies Market
       3.7. Monoclonal Antibodies Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Production Type
           3.7.3 Market Attractive Analysis by Indication
           3.7.4 Market Attractive Analysis by End-Use
           3.7.5 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Monoclonal Antibodies Value Chain Analysis
       4.2. Monoclonal Antibodies Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Monoclonal Antibodies Raw Material Manufactures List
           4.2.3. Price Trend of Monoclonal Antibodies Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Monoclonal Antibodies Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Monoclonal Antibodies Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Monoclonal Antibodies Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Monoclonal Antibodies Market

6 . GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical Data 2015-2018
       6.3 Global Monoclonal Antibodies Market Analysis by Type
       6.4 Market Analysis of Murine by Regions
       6.6 Market Analysis of Chimeric by Regions
       6.5 Market Analysis of Humanized by Regions
       6.7 Market Analysis of Human by Regions
       6.8 Market Analysis of Other by Regions

7 . GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY PRODUCTION TYPE
       7.1 Overview by Production Type
       7.2 Historical Data 2015-2018
       7.3 Global Monoclonal Antibodies Market Analysis by Production Type
       7.4 Market Analysis of In Vivo by Regions
       7.5 Market Analysis of In Vitro by Regions

8 . GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY INDICATION
       8.1 Overview by Indication
       8.2 Historical Data 2015-2018
       8.3 Global Monoclonal Antibodies Market Analysis by Indication
       8.4 Market Analysis of Cancer by Regions
       8.5 Market Analysis of Autoimmune Diseases by Regions
       8.6 Market Analysis of Inflammatory Diseases by Regions
       8.7 Market Analysis of Infectious Diseases by Regions
       8.8 Market Analysis of Microbial Diseases by Regions
       8.9 Market Analysis of Others by Regions

9 . GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY END-USE
       9.1 Overview by End-Use
       9.2 Historical Data 2015-2018
       9.3 Global Monoclonal Antibodies Market Analysis by End-Use
       9.4 Market Analysis of Hospitals by Regions
       9.5 Market Analysis of Research Institutes by Regions
       9.6 Market Analysis of Others by Regions

10 . GLOBAL MONOCLONAL ANTIBODIES MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America
           10.3.1. Overview and Historic Data
           10.3.2. North America Monoclonal Antibodies Market Estimate By Market Segment
           10.3.3. North America Monoclonal Antibodies Market Estimate By Country
           10.3.4. United State
           10.3.5. Canada
           10.3.6. Mexico
       10.4. Europe
           10.4.1. Overview and Historic Data
           10.4.2. Europe Monoclonal Antibodies Market Estimate by Market Segment
           10.4.3. Europe Monoclonal Antibodies Market Estimate by Country
           10.4.4. United Kingdom
           10.4.5. France
           10.4.6. Germany
           10.4.7. Italy
           10.4.8. Russia
           10.4.9. Rest Of Europe
       10.5. Asia Pacific
           10.5.1. Overview and Historic Data
           10.5.2. Asia Pacific Monoclonal Antibodies Market Estimate by Market Segment
           10.5.3. Asia Pacific Monoclonal Antibodies Market Estimate by Country
           10.5.4. China
           10.5.5. India
           10.5.6. Japan
           10.5.7. South Korea
           10.5.8. Australia
           10.5.9. Rest Of Asia Pacific
       10.6. Latin America
           10.6.1. Overview and Historic Data
           10.6.2. Latin America Monoclonal Antibodies Market Estimate by Market Segment
           10.6.3. Latin America Monoclonal Antibodies Market Estimate by Country
           10.6.4. Brazil
           10.6.5. Argentina
           10.6.6. Peru
           10.6.7. Chile
           10.6.8. Rest of Latin America
       10.7. Middle East & Africa
           10.7.1. Overview and Historic Data
           10.7.2. Middle East & Africa Monoclonal Antibodies Market Estimate by Market Segment
           10.7.3. Middle East & Africa Monoclonal Antibodies Market Estimate by Country
           10.7.4. Saudi Arabia
           10.7.5. UAE
           10.7.6. Israel
           10.7.7. South Africa
           10.7.8. Rest Of Middle East And Africa

11 COMPETITIVE LANDSCAPE OF THE MONOCLONAL ANTIBODIES COMPANIES
       11.1. Monoclonal Antibodies Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments

12 COMPANY PROFILES OF MONOCLONAL ANTIBODIES INDUSTRY
       12.1. Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Roche
           12.3.1. Company Overview
           12.3.2. Financials
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. Eli Lilly
           12.4.1. Company Overview
           12.4.2. Financials
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. Genentech
           12.5.1. Company Overview
           12.5.2. Financials
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Pfizer
           12.6.1. Company Overview
           12.6.2. Financials
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. Biogen Idec
           12.7.1. Company Overview
           12.7.2. Financials
           12.7.3. Products
           12.7.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "